论文信息 - LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer - 字舞流文

LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer

Xiu-juan Yuan | J. Manro | Sheng-Bin Peng | Wayne D. Blosser | M. Dowless | L. Stancato | N. Simpson | Youyan Zhang | S. Jaken | S. Pratt | L. Huber | J. Stephens | Eliza Vakana | X. Yuan